US court rules on reverse payment patent settlement

01-06-2010

The US Court of Appeals for the Second Circuit ruled on April 29 that a so-called ‘reverse payment patent settlement’ between pharmaceutical company Bayer and three generic drugs companies did not violate US antitrust laws.


US, Court of Appeals, Bayer, reverse, payment, patents

WIPR